314 related articles for article (PubMed ID: 27001354)
21. Stroke prevention using dabigatran in elderly Chinese patients with atrial fibrillation.
Chan PH; Huang D; Hai JJ; Li WH; Yin LX; Chan EW; Wong IC; Lau CP; Chiang CE; Zhu J; Tse HF; Siu CW
Heart Rhythm; 2016 Feb; 13(2):366-73. PubMed ID: 26392326
[TBL] [Abstract][Full Text] [Related]
22. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
Agarwal S; Bennett D; Smith DJ
Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
[TBL] [Abstract][Full Text] [Related]
23. Assessing the risk of bleeding in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation project.
Lip GY; Banerjee A; Lagrenade I; Lane DA; Taillandier S; Fauchier L
Circ Arrhythm Electrophysiol; 2012 Oct; 5(5):941-8. PubMed ID: 22923275
[TBL] [Abstract][Full Text] [Related]
24. Atrial fibrillation and medication treatment among centenarians: Are all very old patients treated the same?
Kreutz R; Schmidt IM; Dräger D; Brüggen F; Hörter S; Zwillich C; Kuhlmey A; Gellert P
Geriatr Gerontol Int; 2018 Dec; 18(12):1634-1640. PubMed ID: 30259631
[TBL] [Abstract][Full Text] [Related]
25. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
[TBL] [Abstract][Full Text] [Related]
26. Do CHA2 DS2 VASc and HAS-BLED scores influence 'real-world' anticoagulation management in atrial fibrillation? 1556 patient registry from the reference cardiology centre.
Lopatowska P; Tomaszuk-Kazberuk A; Mlodawska E; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S; Musial WJ
Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1297-303. PubMed ID: 26419506
[TBL] [Abstract][Full Text] [Related]
27. Can we predict stroke in atrial fibrillation?
Lip GY
Clin Cardiol; 2012 Jan; 35 Suppl 1(Suppl 1):21-7. PubMed ID: 22246948
[TBL] [Abstract][Full Text] [Related]
28. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
[TBL] [Abstract][Full Text] [Related]
29. The Effect of Bleeding Risk and Frailty Status on Anticoagulation Patterns in Octogenarians With Atrial Fibrillation: The FRAIL-AF Study.
Lefebvre MC; St-Onge M; Glazer-Cavanagh M; Bell L; Kha Nguyen JN; Viet-Quoc Nguyen P; Tannenbaum C
Can J Cardiol; 2016 Feb; 32(2):169-76. PubMed ID: 26277091
[TBL] [Abstract][Full Text] [Related]
30. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
31. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.
Apostolakis S; Lane DA; Guo Y; Buller H; Lip GY
J Am Coll Cardiol; 2012 Aug; 60(9):861-7. PubMed ID: 22858389
[TBL] [Abstract][Full Text] [Related]
32. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
[TBL] [Abstract][Full Text] [Related]
33. Atrial fibrillation and stroke prevention: brief observations on the last decade.
Lip GY
Expert Rev Cardiovasc Ther; 2014 Apr; 12(4):403-6. PubMed ID: 24650307
[TBL] [Abstract][Full Text] [Related]
34. Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation: the AMADEUS Study.
Lip GYH; Lane DA; Buller H; Apostolakis S
Chest; 2013 Dec; 144(6):1839-1847. PubMed ID: 24009027
[TBL] [Abstract][Full Text] [Related]
35. Burden of atrial fibrillation: a retrospective review of patients presenting to acute medical services.
Jolliffe E; Fu V; Lanford J; Weatherall M; Rosemergy I
Intern Med J; 2016 Oct; 46(10):1166-1171. PubMed ID: 27501863
[TBL] [Abstract][Full Text] [Related]
36. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
[TBL] [Abstract][Full Text] [Related]
37. Stroke prevention in atrial fibrillation: a systematic review.
Lip GY; Lane DA
JAMA; 2015 May; 313(19):1950-62. PubMed ID: 25988464
[TBL] [Abstract][Full Text] [Related]
38. Advances in stroke prevention in atrial fibrillation: enhanced risk stratification combined with the newer oral anticoagulants.
Verheugt FW
Clin Cardiol; 2013 Jun; 36(6):312-22. PubMed ID: 23568790
[TBL] [Abstract][Full Text] [Related]
39. β-Trace protein and prognosis in patients with atrial fibrillation receiving anticoagulation treatment.
Vílchez JA; Roldán V; Manzano-Fernández S; Fernández H; Avilés-Plaza F; Martínez-Hernández P; Vicente V; Valdés M; Marín F; Lip GYH
Chest; 2013 Nov; 144(5):1564-1570. PubMed ID: 23975142
[TBL] [Abstract][Full Text] [Related]
40. The prevalence of atrial fibrillation in a geographically well-defined population in northern Sweden: implications for anticoagulation prophylaxis.
Andersson P; Löndahl M; Abdon NJ; Terent A
J Intern Med; 2012 Aug; 272(2):170-6. PubMed ID: 22250988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
